Effect of Gastric Electrical Stimulation on Serum Insulin Levels

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint added 1 → 2 primary endpoints
See other at-risk trials from Indiana University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 5 more changesShow less
    • Study sites: 2 to 1
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: 3 to 2
    • Study description shortened, about 162 words
    • Publications: details revised at 5 of 5 entries
  2. Study completion moved earlier from Sep 30, 2030 to Jul 31, 2028
    • Start date changed from estimate of Jun 8, 2026 to Jul 23, 2026
    • Secondary endpoints: details revised at 3 of 3 entries
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine how much effect turning off an individual's Gastric Electrical Stimulator (GES) for up to four hours will have on levels of insulin, C-peptide, GLP-1 and glucose levels.
Trial Details
NCT Number NCT07635576
Lead Sponsor Indiana University
Conditions
(from sponsor)		 Gastroparesis Nondiabetic
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov